Genpharmasec Ltd Experiences Notable Buying Activity Amid Broader Market Decline
2025-04-03 10:35:12Genpharmasec Ltd is currently witnessing significant buying activity, marking a notable performance in the trading sector. The stock has gained 1.55% today, contrasting sharply with the Sensex, which has declined by 0.24%. Over the past week, Genpharmasec has recorded a total increase of 2.08%, while the Sensex has fallen by 1.51%. This trend of consecutive gains is evident, as the stock has risen for three consecutive days, accumulating a total return of 3.7% during this period. Despite this recent uptick, Genpharmasec's longer-term performance remains challenging. Over the past month, the stock has decreased by 2.97%, and its year-to-date performance shows a decline of 36.57%. The stock is currently trading close to its 52-week low, just 3.57% above Rs 1.89. The buying pressure may be attributed to various factors, including market sentiment and potential sector-specific developments. Notably, Genpharma...
Read MoreGenpharmasec Ltd Experiences Increased Buying Activity Amid Ongoing Price Challenges
2025-04-02 11:25:08Genpharmasec Ltd is currently witnessing strong buying activity, with the stock gaining 1.58% today, outperforming the Sensex, which rose by 0.61%. This marks the second consecutive day of gains for Genpharmasec, with a total increase of 2.12% over this period. However, the stock's performance over the past month shows a decline of 4.46%, contrasting sharply with the Sensex's increase of 4.50%. Despite today's positive movement, Genpharmasec has faced significant challenges over longer time frames, including a 40.98% drop over the past three months and a staggering 75.18% decline over the last five years. The stock is currently trading close to its 52-week low, just 2.07% above Rs 1.89. The buying pressure may be attributed to various factors, including market sentiment and potential sector-specific developments. Notably, Genpharmasec is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving...
Read MoreGenpharmasec Ltd Sees Increased Buying Activity Amidst Ongoing Market Challenges
2025-04-01 11:40:19Genpharmasec Ltd is currently witnessing strong buying activity, marking a notable shift after five consecutive days of decline. Today, the stock has increased by 1.06%, contrasting sharply with the Sensex, which has decreased by 1.52%. This performance indicates a potential reversal in sentiment for Genpharmasec, especially as it has underperformed its sector by 2.06%. Over the past week, Genpharmasec has seen a decline of 3.54%, while the Sensex has fallen by 2.28%. In the longer term, the stock has struggled, with a 43.15% drop over the past three months and a staggering 75.43% decline over the past five years, compared to the Sensex's impressive 169.73% gain during the same period. Today's trading session opened with a gap up, and the stock is currently just 1.05% away from its 52-week low of Rs 1.89. Despite the recent uptick, Genpharmasec continues to trade below its 5-day, 20-day, 50-day, 100-day, ...
Read MoreGenpharmasec Ltd Faces Intense Selling Pressure Amid Consecutive Losses and New 52-Week Low
2025-03-28 12:25:09Genpharmasec Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past five days, resulting in a total decline of 7.32%. Today, Genpharmasec's stock price fell by 1.56%, underperforming the Sensex, which decreased by only 0.23%. Over the past week, Genpharmasec has seen a notable decline of 7.80%, while the Sensex has gained 0.68%. The stock's performance over the last month is similarly concerning, with a drop of 6.44% compared to the Sensex's increase of 5.78%. Year-to-date, Genpharmasec has plummeted by 38.83%, contrasting sharply with the Sensex's modest decline of 0.91%. The stock has reached a new 52-week low of Rs. 1.89 today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. These trends indicate a persistent downward trajectory, raising questions about the underl...
Read More
Genpharmasec Faces Market Challenges Despite Growth in Sales and Profits
2025-03-28 10:36:24Genpharmasec has faced significant volatility, reaching a new 52-week low and underperforming its sector. Despite a 132.2% increase in profits and a 22% rise in net sales, the company's low return on equity and high valuation contribute to a cautious market sentiment amid ongoing challenges.
Read MoreGenpharmasec Ltd Faces Intense Selling Pressure Amid Continued Price Declines
2025-03-27 11:20:10Genpharmasec Ltd is currently facing significant selling pressure, with today's trading session showing only sellers in the market. The stock has recorded a decline of 1.54% today, underperforming the Sensex, which has gained 0.49%. This marks the fourth consecutive day of losses for Genpharmasec, with a total drop of 6.34% over this period. In terms of longer-term performance, Genpharmasec has struggled significantly. Over the past week, the stock has decreased by 5.88%, and it has seen a staggering 40% decline over the last three months. Year-to-date, the stock is down 37.86%, while its performance over the past five years shows a dramatic drop of 75.40%. Today, Genpharmasec hit a new 52-week low of Rs. 1.92, indicating ongoing challenges. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further highlighting its weak market position. The persistent selling pre...
Read MoreGenpharmasec Ltd Faces Intense Selling Pressure Amid Consecutive Losses and Declining Stock Performance
2025-03-26 11:25:14Genpharmasec Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past three days, resulting in a total decline of 4.88%. In terms of daily performance, Genpharmasec's stock fell by 1.52%, significantly underperforming the Sensex, which decreased by only 0.21%. Over the past week, Genpharmasec has seen a decline of 2.50%, while the Sensex has gained 3.19%. The stock's performance over the past month is similarly concerning, with a drop of 6.25% compared to the Sensex's increase of 4.36%. More alarmingly, Genpharmasec's three-month performance shows a staggering decline of 38.68%, while the Sensex has remained relatively stable with a decrease of just 0.79%. The stock is currently trading close to its 52-week low, just 1.54% away from Rs 1.92. Additionally, Genpharmasec is trading below its 5-day, 20-day, 50...
Read MoreGenpharmasec Ltd Sees Increased Buying Activity Amid Broader Market Gains
2025-03-20 12:25:06Genpharmasec Ltd is currently witnessing strong buying activity, marking a notable performance shift after seven consecutive days of decline. Today, the stock has increased by 2.00%, significantly outperforming the Sensex, which has risen by 0.67%. Despite this uptick, Genpharmasec's performance over the past week shows a decline of 2.86%, contrasting with the Sensex's gain of 2.88%. In terms of price summary, Genpharmasec is currently trading 4.48% above its 52-week low of Rs 1.92. The stock has opened with a gap up, indicating positive market sentiment. However, it remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a longer-term bearish trend. The recent buying pressure may be attributed to sector-wide gains, as the trading sector has seen an increase of 3.45%. Despite the current buying momentum, Genpharmasec's year-to-date performance remains negative at -33.98%,...
Read MoreGenpharmasec Ltd Faces Intense Selling Pressure Amid Consecutive Losses and Declining Performance
2025-03-18 11:25:08Genpharmasec Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The trading activity reflects a concerning trend, as the stock has experienced consecutive losses over the past six days, resulting in a total decline of 13.3%. In terms of performance, Genpharmasec has underperformed relative to the Sensex across various time frames. Today, the stock fell by 1.94%, while the Sensex gained 1.11%. Over the past week, Genpharmasec's decline of 7.34% starkly contrasts with the Sensex's modest increase of 1.21%. The stock's longer-term performance is equally troubling, with a staggering 40.41% drop over the past three months and a 34.63% decline year-to-date, compared to the Sensex's decrease of only 4.02%. Currently, Genpharmasec is trading close to its 52-week low, just 4.95% above Rs 1.92. The stock is also trading below its 5-day, 20-day, 50-day, 100-day, and 200...
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Apr-2025 | Source : BSECertificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended March 31 2025.
Closure of Trading Window
25-Mar-2025 | Source : BSEIntimation of Closure of Trading Window
Board Meeting Outcome for Outcome Of The Separate Meeting Of Independent Directors Of The Company.
24-Mar-2025 | Source : BSEOutcome of the Separate Meeting of Independent Directors of the Company Held on Monday March 24 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Genpharmasec Ltd has announced 1:10 stock split, ex-date: 11 Apr 19
No Bonus history available
Genpharmasec Ltd has announced 1:1 rights issue, ex-date: 09 Jan 24